TY  - GEN
AU  - Aghajanian,Carol
AU  - Sill,Michael W
AU  - Darcy,Kathleen M
AU  - Greer,Benjamin
AU  - McMeekin,D Scott
AU  - Rose,Peter G
AU  - Rotmensch,Jacob
AU  - Barnes,Mack N
AU  - Hanjani,Parviz
AU  - Leslie,Kimberly K
TI  - Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study
SN  - 1527-7755
PY  - 2011///0728
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Bevacizumab
KW  - Disease-Free Survival
KW  - Endometrial Neoplasms
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Salvage Therapy
KW  - methods
KW  - Vascular Endothelial Growth Factor A
KW  - biosynthesis
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2010.32.6397
ER  -